By Tony Huge | tonyhuge.is | February 2025
Dear Secretary Kennedy,
I’m writing to you because you’ve spent your career fighting for something I believe in deeply: the right of every American to make informed decisions about their own health. You’ve challenged pharmaceutical monopolies. You’ve questioned regulatory capture. You’ve advocated for transparency in a system that profits from keeping people sick and dependent.
I’m asking you to bring that same courage to the peptide conversation.
The Compounds Under Threat
Right now, the FDA is moving to restrict access to some of the most promising healing compounds ever studied. BPC-157 — Body Protection Compound 157 — is a 15-amino-acid peptide derived from a protein naturally found in human gastric juice. Your body already makes a version of it. Over 100 published studies demonstrate its ability to accelerate healing in tendons, ligaments, muscles, the gut lining, and even the nervous system.
TB-500, a synthetic fragment of Thymosin Beta-4, promotes cell migration and tissue repair at a systemic level. GHK-Cu, a copper-binding tripeptide, modulates the expression of over 4,000 human genes involved in tissue remodeling, collagen synthesis, and wound healing.
These are not designer drugs. These are molecules your body already produces. Researchers have been studying them for decades. And millions of Americans are using them — safely, effectively, and often after conventional medicine failed them.
The Real-World Impact
I hear from people every single day. Veterans who healed chronic injuries that the VA couldn’t fix. Athletes who avoided surgery. Everyday Americans who recovered gut health after years of NSAID damage. People who got their mobility back, their quality of life back, their independence back.
These aren’t recreational users. These are people seeking healing. And they found it in peptides that the FDA now wants to make inaccessible.
The Regulatory Problem
The FDA’s approach to peptides follows a familiar pattern. Rather than creating a sensible regulatory framework that ensures quality and access, the agency defaults to restriction. Category 2 designations. Warning letters to compounding pharmacies. Vague guidance that creates legal uncertainty for practitioners and patients alike.
This approach doesn’t protect consumers. It drives them to unregulated markets with no quality control. It punishes the compounding pharmacies that provide affordable, tested products while protecting the pharmaceutical companies that charge $1,000+ for FDA-approved versions of the same molecules.
BPC-157 costs roughly $40-60 per vial from a reputable compounding pharmacy. The pharmaceutical industry knows that if peptides gain mainstream acceptance at those prices, their margins on conventional treatments collapse. The regulatory push against peptides isn’t about safety. It’s about market control.
What I’m Asking
Secretary Kennedy, I’m asking you to do what you’ve always done — question the narrative and follow the evidence.
I’m asking you to examine the published research on BPC-157, TB-500, GHK-Cu, and other healing peptides. I’m asking you to hear from the millions of Americans who depend on access to these compounds. I’m asking you to create a regulatory pathway that ensures quality and safety without eliminating access.
Specifically, I’m requesting consideration for three things. First, protect compounding pharmacy access to peptides that have established safety profiles and decades of published research. Second, fund human clinical trials on BPC-157 and other widely-used peptides so the evidence base matches the real-world experience. Third, create a regulatory category for naturally-occurring peptides that acknowledges their fundamentally different risk profile from synthetic pharmaceuticals.
The Health Freedom Argument
You’ve said that Americans deserve the right to make their own health decisions. Peptides are the frontier of that fight. These are healing molecules that the body already recognizes. They’re affordable. They’re accessible through compounding pharmacies. And they work.
Restricting access to peptides while protecting pharmaceutical monopolies on inferior treatments is exactly the kind of regulatory capture you’ve spent your career exposing.
The peptide community is watching. Millions of Americans who use these compounds for healing are counting on you to protect their access. This is a health freedom issue, and there is no one better positioned to champion it.
In Closing
I’ve dedicated my life to human optimization and helping people take control of their own biology. I’ve seen what peptides can do. I’ve seen injuries heal that doctors said were permanent. I’ve seen gut health restored after years of suffering. I’ve seen quality of life transformed.
These molecules deserve protection, not prohibition. The Americans who depend on them deserve a champion in government.
I believe you can be that champion.
Respectfully,
Tony Huge
Founder of the Enhanced Movement
Advocate for Health Freedom and Human Optimization
Disclaimer: This letter represents the personal views of Tony Huge. Nothing in this letter constitutes medical advice. Peptides discussed are not FDA-approved for human use. Always consult a licensed physician before using any compound.